Heart failure with preserved ejection fraction (HFpEF): More …
May 20, 2015 · HFpEF is a syndrome of heart failure with preserved ejection fraction, often caused by hypertension and aging. Learn about the symptoms, risk factors, diagnostic criteria and treatment options for this complex and heterogeneous condition.
2023 ACC Expert Consensus on Management of HFpEF: Key Points
Apr 19, 2023 · HFpEF is heart failure with preserved ejection fraction, defined as signs and symptoms of HF with LVEF ≥50%. Learn about the diagnosis, comorbidities, scoring systems, and treatment options for HFpEF from a 2023 ACC report.
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure…
Apr 1, 2022 · HF indicates heart failure; HFimpEF, heart failure with improved ejection fraction; HFmrEF, heart failure with mildly reduced ejection fraction; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; and LVEF, left ventricular ejection fraction.
Semaglutide in Patients with Heart Failure with Preserved Ejection ...
Aug 25, 2023 · In this randomized, placebo-controlled trial involving patients with heart failure with preserved ejection fraction and obesity, once weekly semaglutide at a dose of 2.4 mg led to larger...
Heart failure with preserved ejection fraction: everything the ...
Mar 16, 2024 · HFpEF is heart failure with preserved ejection fraction, meaning left ventricular ejection fraction is 50% or higher. Learn about the challenges of diagnosing HFpEF, the latest research and guidelines, and the treatment options for this complex syndrome.
Scientists discover potential new treatment for heart failure with ...
Sep 30, 2024 · Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ejection fraction (HFpEF), a type of heart disease that is notoriously...
News Release - Eli Lilly and Company
Aug 1, 2024 · Tirzepatide, a once-weekly injection for diabetes, improved heart failure outcomes and symptoms in adults with obesity and heart failure with preserved ejection fraction (HFpEF). The phase 3 SUMMIT trial showed a 38% risk reduction and a 15.7% weight loss with tirzepatide compared to placebo.
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Aug 27, 2021 · In patients with heart failure and a preserved ejection fraction, SGLT2 inhibition with empagliflozin led to a 21% lower relative risk in the composite of cardiovascular death or...
Heart failure with preserved ejection fraction - Nature
Aug 14, 2024 · Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure cases and has a prevalence that is expected to rise with the growing ageing...
Clinical Update in Heart Failure with Preserved Ejection Fraction
Sep 3, 2024 · Recent findings: Heart failure with preserved ejection fraction makes up approximately half of overall heart failure and is associated with significant morbidity, mortality, and overall burden on the healthcare system.